• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与胃癌相关的临床证据

The Clinical Evidence Linking to Gastric Cancer.

作者信息

Moss Steven F

机构信息

Gastroenterology Division, Rhode Island Hospital, Brown University, Providence, Rhode Island.

出版信息

Cell Mol Gastroenterol Hepatol. 2016 Dec 27;3(2):183-191. doi: 10.1016/j.jcmgh.2016.12.001. eCollection 2017 Mar.

DOI:10.1016/j.jcmgh.2016.12.001
PMID:28275685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5331857/
Abstract

Gastric cancer has long been recognized to be accompanied and preceded by chronic gastritis, lasting decades. Arguably, the most important development in our understanding of gastric cancer pathogenesis over the past 50 years has been the realization that, for most cases of gastric cancer, is the cause of the underlying gastritis. Gastritis can promote gastric carcinogenesis, typically via the Correa cascade of atrophic gastritis, intestinal metaplasia, and dysplasia. Nested case-control studies have shown that infection increases the risk of gastric cancer significantly, both of the intestinal and diffuse subtypes, and that is responsible for approximately 90% of the world's burden of noncardia gastric cancer. Based largely on randomized studies in high gastric cancer prevalence regions in East Asia, it appears that primary and tertiary intervention to eradicate can halve the risk of gastric cancer. Some public health authorities now are starting screening and treatment programs to reduce the burden of gastric cancer in these high-risk areas. However, there is currently much less enthusiasm for initiating similar attempts in the United States. This is partially because gastric cancer is a relatively less frequent cause of cancer in the United States, and in addition there are concerns about theoretical downsides of eradication, principally because of the consistent inverse relationship noted between and esophageal adenocarcinoma. Nevertheless, establishing a link between chronic infection and gastric cancer has led to novel insights into cancer biology, the gastrointestinal microbiome, and on individual and population-based gastric cancer prevention strategies.

摘要

长期以来,人们一直认识到胃癌常伴有慢性胃炎,且在其之前就已存在,这种情况可持续数十年。可以说,在过去50年里,我们对胃癌发病机制认识的最重要进展是意识到,对于大多数胃癌病例来说,[此处原文缺失关键信息]是潜在胃炎的病因。胃炎可促进胃癌发生,通常是通过萎缩性胃炎、肠化生和发育异常的科雷亚级联反应。巢式病例对照研究表明,[此处原文缺失关键信息]感染显著增加胃癌风险,包括肠型和弥漫型亚型,并且[此处原文缺失关键信息]导致了全球约90%的非贲门胃癌负担。主要基于东亚胃癌高发地区的随机研究,根除[此处原文缺失关键信息]的一级和三级干预似乎可使胃癌风险减半。一些公共卫生当局现在开始启动筛查和治疗项目,以减轻这些高危地区的胃癌负担。然而,目前在美国开展类似尝试的热情要低得多。部分原因是胃癌在美国是相对不常见的癌症病因,此外,人们担心根除[此处原文缺失关键信息]存在理论上的不利之处,主要是因为[此处原文缺失关键信息]与食管腺癌之间存在持续的负相关关系。尽管如此,建立慢性[此处原文缺失关键信息]感染与胃癌之间的联系,为癌症生物学、胃肠道微生物群以及基于个体和人群的胃癌预防策略带来了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf2/5331857/022d95e978b6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf2/5331857/a6fa531c9e1d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf2/5331857/18613a82ef6b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf2/5331857/022d95e978b6/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf2/5331857/a6fa531c9e1d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf2/5331857/18613a82ef6b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cf2/5331857/022d95e978b6/gr3.jpg

相似文献

1
The Clinical Evidence Linking to Gastric Cancer.与胃癌相关的临床证据
Cell Mol Gastroenterol Hepatol. 2016 Dec 27;3(2):183-191. doi: 10.1016/j.jcmgh.2016.12.001. eCollection 2017 Mar.
2
Chronic gastritis, intestinal metaplasia, dysplasia and Helicobacter pylori in gastric cancer: putting the pieces together.慢性胃炎、肠化生、发育异常与胃癌中的幽门螺杆菌:综合分析
Ital J Gastroenterol. 1994 Dec;26(9):449-58.
3
Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.幽门螺杆菌相关的胃黏膜肠化生:治疗与监测
World J Gastroenterol. 2016 Jan 21;22(3):1311-20. doi: 10.3748/wjg.v22.i3.1311.
4
Eradication of gastric cancer is now both possible and practical.胃癌的根治现在既可行又实际。
Semin Cancer Biol. 2013 Dec;23(6 Pt B):492-501. doi: 10.1016/j.semcancer.2013.07.004. Epub 2013 Jul 19.
5
[The effect of Helicobacter pylori eradication on chronic gastritis].[幽门螺杆菌根除对慢性胃炎的影响]
Nihon Rinsho. 2013 Aug;71(8):1442-8.
6
Helicobacter pylori and Gastric Cancer: Timing and Impact of Preventive Measures.幽门螺杆菌与胃癌:预防措施的时机及影响
Adv Exp Med Biol. 2016;908:409-18. doi: 10.1007/978-3-319-41388-4_20.
7
Gastric cancer--a long-term consequence of Helicobacter pylori infection?胃癌——幽门螺杆菌感染的长期后果?
Scand J Gastroenterol Suppl. 1994;201:24-7.
8
[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].[根据胃黏膜炎症病变程度评估幽门螺杆菌感染患者胃液中一氧化氮代谢产物]
Pol Merkur Lekarski. 2008 Feb;24(140):95-100.
9
Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.基于血清胃蛋白酶原和幽门螺杆菌抗体滴度评估的慢性活动性胃炎和由此导致的胃萎缩与癌症发展的关系。
Int J Cancer. 2014 Mar 15;134(6):1445-57. doi: 10.1002/ijc.28470. Epub 2013 Oct 3.
10
Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?胃切迹、胃体和胃底的窦型黏膜(胃窦化):幽门螺杆菌感染与肠化生之间的联系?
Am J Gastroenterol. 2000 Jan;95(1):114-21. doi: 10.1111/j.1572-0241.2000.01609.x.

引用本文的文献

1
Why internists should care about Helicobacter pylori: recapitulating gastric cancer prevention.内科医生为何应关注幽门螺杆菌:重温胃癌预防
Intern Emerg Med. 2025 Aug 31. doi: 10.1007/s11739-025-04104-0.
2
Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head-To-Head Comparison of Lateral Flow and Enzyme-Linked Immunosorbent Assays.萎缩性胃炎中胃蛋白酶原I、II、胃泌素17和幽门螺杆菌IgG的评估:侧向流动分析法与酶联免疫吸附测定法的直接比较
Helicobacter. 2025 Jul-Aug;30(4):e70066. doi: 10.1111/hel.70066.
3
Gut modulation to regulate NF-κB in colorectal and gastric cancer therapy and inflammation.

本文引用的文献

1
Mycins v Microbes Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues by Martin J. Blaser (2014) Holt New York, USA.《霉菌与微生物 缺失的微生物:抗生素的过度使用如何引发现代瘟疫》 作者:马丁·J·布莱泽(2014年) 美国纽约霍尔特出版社
FASEB J. 2014 Sep;28(9):3821-3822. doi: 10.1096/fj.14-0901ufm.
2
Native and bone marrow-derived cell mosaicism in gastric carcinoma in H. pylori-infected p27-deficient mice.幽门螺杆菌感染的p27基因缺陷小鼠胃癌中的天然细胞和骨髓来源细胞嵌合现象
Oncotarget. 2016 Oct 25;7(43):69136-69148. doi: 10.18632/oncotarget.12049.
3
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
肠道调节在结直肠癌和胃癌治疗及炎症中对核因子-κB的调控作用
Cancer Immunol Immunother. 2025 Jul 12;74(8):264. doi: 10.1007/s00262-025-04118-9.
4
Recommendations and Adjuvant Therapies to Mitigate Clarithromycin-Resistant -Associated Infections in Africa.减轻非洲地区克拉霉素耐药相关感染的建议及辅助治疗方法
Infect Drug Resist. 2025 Jun 26;18:3169-3174. doi: 10.2147/IDR.S528422. eCollection 2025.
5
Serum pro-inflammatory cytokines as potential biomarkers for the diagnosis of gastric carcinoma.血清促炎细胞因子作为胃癌诊断的潜在生物标志物。
World J Clin Oncol. 2025 May 24;16(5):107551. doi: 10.5306/wjco.v16.i5.107551.
6
Gastric Cancer Genetics and Its Implications for Diagnosis, Prognosis, and Treatment of the Disease.胃癌遗传学及其对该疾病诊断、预后和治疗的意义。
Korean J Helicobacter Up Gastrointest Res. 2024 Jun;24(2):103-112. doi: 10.7704/kjhugr.2024.0018. Epub 2024 Jun 10.
7
[Precision Medicine for Gastric Cancer: Applicability from the Perspective of Infection].[胃癌的精准医学:从感染角度看其适用性]
Korean J Helicobacter Up Gastrointest Res. 2023 Sep;23(3):231-233. doi: 10.7704/kjhugr.2023.0030. Epub 2023 Sep 8.
8
The potential value of serum pepsinogen and gastrin-17 for the diagnosis of chronic atrophic gastritis at different stages of severity: a clinical diagnostic study.血清胃蛋白酶原和胃泌素-17在不同严重程度慢性萎缩性胃炎诊断中的潜在价值:一项临床诊断研究
BMC Gastroenterol. 2025 Jun 4;25(1):428. doi: 10.1186/s12876-025-03996-8.
9
Current Understanding of Optimal Prevention of Helicobacter pylori-Induced Cancer.幽门螺杆菌诱发癌症的最佳预防现状
Gastroenterol Clin North Am. 2025 Jun;54(2):397-413. doi: 10.1016/j.gtc.2024.12.005. Epub 2025 Jan 24.
10
A Reverse Vaccinology and Immunoinformatic Approach for the Designing of a Novel mRNA Vaccine Against Stomach Cancer Targeting the Potent Pathogenic Proteins of .一种用于设计针对胃癌的新型mRNA疫苗的反向疫苗学和免疫信息学方法,该疫苗靶向……的强效致病蛋白。
Bioinform Biol Insights. 2025 Apr 16;19:11779322251331104. doi: 10.1177/11779322251331104. eCollection 2025.
幽门螺杆菌根除与胃癌发病率的关系:系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
4
Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis.弯曲菌属和幽门螺杆菌属在炎症性肠病中的双重作用:系统评价和荟萃分析。
Gut. 2017 Feb;66(2):235-249. doi: 10.1136/gutjnl-2015-310545. Epub 2015 Oct 27.
5
Helicobacter pylori virulence factors in development of gastric carcinoma.幽门螺杆菌毒力因子在胃癌发生中的作用
Future Microbiol. 2015;10(9):1505-16. doi: 10.2217/fmb.15.72. Epub 2015 Sep 7.
6
Current Status and Prospects for a Helicobacter pylori Vaccine.幽门螺杆菌疫苗的现状与前景
Gastroenterol Clin North Am. 2015 Sep;44(3):677-89. doi: 10.1016/j.gtc.2015.05.013. Epub 2015 Jul 7.
7
Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.根除幽门螺杆菌以消除胃癌:日本的策略。
Gastroenterol Clin North Am. 2015 Sep;44(3):639-48. doi: 10.1016/j.gtc.2015.05.010. Epub 2015 Jul 15.
8
Helicobacter pylori eradication for the prevention of gastric neoplasia.根除幽门螺杆菌以预防胃部肿瘤
Cochrane Database Syst Rev. 2015 Jul 22;2015(7):CD005583. doi: 10.1002/14651858.CD005583.pub2.
9
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial.中国儿童口服重组幽门螺杆菌疫苗的有效性、安全性和免疫原性:一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2015 Oct 10;386(10002):1457-64. doi: 10.1016/S0140-6736(15)60310-5. Epub 2015 Jun 30.
10
Composition, structure and function of the Helicobacter pylori cag pathogenicity island encoded type IV secretion system.幽门螺杆菌cag致病岛编码的IV型分泌系统的组成、结构与功能
Future Microbiol. 2015;10(6):955-65. doi: 10.2217/fmb.15.32.